Bristol-Myers Squibb Co - Company Profile
Powered by 
All the data and insights you need on Bristol-Myers Squibb Co in one report.
$295
- Save hours of research time and resources with
our up-to-date Bristol-Myers Squibb Co Strategy Report
- Understand Bristol-Myers Squibb Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
View moreThe following section provides information on Bristol-Myers Squibb Co’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Bristol-Myers Squibb Co's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Christopher S. Boerner Ph.D.
Chairman; Chief Executive Officer Executive BoardDr. Christopher S. Boerner Ph.D. has been the Chief Executive Officer of the company since November 2023 and Chairman since April 2024. Prior to this, he served as an Executive Vice President and Chief Commercialization Officer of BMS since 2018. Prior to this, he served as the President and the Head of International Markets of the company; Executive Vice President of Commercial, Senior Vice President of Commercial from 2012 to 2014; Vice President of Marketing at Seattle Genetics from 2010 to 2012; Head of Marketing from 2010 and Vice President of Marketing at Dendreon from 2002 to 2010. He held various senior management roles in Gentech including Director of Marketing on Avastin, Director of Avastin franchise management, and Associate Director of Oncology Market Development. He also served at McKinsey & Company in various pharmaceutical sales and marketing engagement roles.
David V. Elkins
Chief Financial Officer; Executive Vice President Senior ManagementMr. David V. Elkins has been the Executive Vice President and the Chief Financial Officer since 2019. Prior to this, he was the Chief Financial Officer of Celgene. Mr. Elkins also served as the Chief Financial Officer and the Worldwide Vice President of Consumer Products, Medical Development and Corporate Functions, Group Vice President and Chief Financial Officer, Consumer and Consumer Medicines at Johnson & Johnson.
Paul von Autenried
Chief Information Officer; Executive Vice President Senior ManagementMr. Paul von Autenried has been the Executive Vice President and the Chief Information Officer of the company since 2019. Prior to this, he served as the Senior Vice President, Enterprise Services and the Chief Information Officer and Head of IT of the company. Prior to that, he held various leadership positions with Kraft General Foods, IBM and Hewlett-Packard.
Kim Jablonski
Executive Vice President; Chief Compliance Officer - Ethics Officer Senior ManagementMs. Kim Jablonski has been the Chief Compliance Officer and Executive Vice President of the company since 2023. Prior to this, she served as Senior Vice President, Head of Major Markets since 2022. She also served as Senior Vice President, General Manager of U.S. Oncology, Immunology & Cardiovascular since 2019 and Head of US Oncology since 2016.
Amanda Poole
Chief Human Resources Officer; Executive Vice President Senior ManagementMs. Amanda Poole has been the Executive Vice President and the Chief Human Resources Officer of the company since 2024. Prior to this, she was the Senior Vice President, People Strategy, Solutions & Services since 2022. Before this, she served as a Senior Vice President, Head of Human Resources, Commercialization since 2020. She also served as a Vice President, Head of BMS/Celgene Integration since 2019.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer